The randomized, double blind, placebo controlled, dose-titration study explored the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatraemia. It
Sound Surgical Technologies has partnered with two Colorado-based companies, Ipax and Front Range Tooling, to produce the new Vaser system tubing and canister products. Dan Goldberger, CEO of
Relistor is now approved in the 27 member states of the EU as well as Iceland, Norway, and Liechtenstein for the treatment of opioid-induced constipation (OIC) in advanced
Linezolid tablets, an antibiotic, are the generic version of Pharmacia and Upjohn’s Zyvox tablets. Currently, Mylan has 93 abbreviated new drug applications pending FDA approval, 21 of which
Under the amended agreement, OncoGenex is solely responsible for all future development activities, costs and partnering decisions related to OGX-011. Isis will no longer be responsible for funding
The agreement with Mitsui will provide MED3OOO with opportunities to expand its vision of being a global ‘premier strategic operations partner’ for those involved in the delivery and
The transaction is Pediatrix’s second anesthesia group practice acquisition and advances the company’s strategy of building a national group practice of anesthesia services to parallel its neonatal, maternal
GeneraMedix’s Epoprostenol for Injection 1.5mg is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA
Mr Murphy, formerly vice president of finance and CFO at Princess House will report directly to James Northrop, president and CEO of Immunotec. Prior to joining Immunotec, Mr
The agreement was a license to manufacture, market, sell and distribute Invicorp in Europe and was terminated pursuant to the company’s contractual rights, precipitated by Ardana’s entry into
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.